A draft of new payment levels released in April proposed lower rates.
Monday, August 5, 2019
Abiomed up on continuation of current reimbursement for Impella heart pump
Abiomed (NASDAQ:ABMD) is up 3% premarket on light volume in reaction to its disclosure that that the present level of Medicare reimbursement for its Impella heart pump for certain procedures will be maintained for fiscal year 2020 (October 1, 2019 – September 30, 2020).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.